Skip to main content

Table 2 Relation between Oct4 expression and clinicopathologic characteristics

From: Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival

 

Total

Low Oct4 (n = 17), N (%)

High Oct4 (n = 28), N (%)

p value

Age in years (mean ± SD)

61.00 ± 10.71

60.61 ± 7.62

0.887

Gender

 Male

28

12 (42.9)

16 (57.1)

0.367

 Female

17

5 (29.4)

12 (70.6)

Location

 Fundus

16

6 (37.5)

10 (62.5)

0.511

 Body

12

3 (25)

9 (75)

 Pylorus

17

8 (47.1)

9 (52.9)

Size

 < 5 cm

15

3 (20)

12 (80)

0.110

 ≥ 5 cm

30

14 (46.7)

16 (53.3)

Gross picture

 Solid

23

8 (34.8)

15 (65.2)

0.672

 Ulcerative

22

9 (40.9)

13 (59.1)

Histologic type (WHO)

 Tubular

32

12 (37.5)

20 (62.5)

0.873

 Mucinous

3

1 (33.3)

2 (66.7)

 Signet ring

7

2 (28.6)

5 (71.4)

 Papillary

3

2 (66.7)

1 (33.3)

Grade

 GI

8

7 (87.5)

1 (12.5)

0.003*

 GII

13

5 (38.5)

8 (61.5)

 GIII

24

5 (20.8)

19 (79.2)

Nodal metastasis

 Negative

15

10 (66.7)

5 (33.3)

0.008*

 Positive

30

7 (23.3)

23 (76.7)

Staging

 I

6

5 (83.3)

1 (16.7)

0.031*

 II

18

7 (38.9)

11 (61.1)

 III

21

5 (23.8)

16 (76.2)

  1. WHO World Health Organization
  2. *Statistically significant